- Home
- ARQT vs NG Comparison
ARQT vs NG Comparison
Compare ARQT & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | NG |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 4.0B |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ARQT | NG |
|---|---|---|
| Price | $20.91 | $7.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $34.00 | $12.22 |
| AVG Volume (30 Days) | 1.8M | ★ 2.9M |
| Earning Date | 05-06-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.85 | N/A |
| Revenue Next Year | $29.39 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $12.72 | $3.42 |
| 52 Week High | $31.77 | $14.40 |
Technical Indicators
Market Signals| Indicator | ARQT | NG |
|---|---|---|
| Relative Strength Index (RSI) | 42.91 | 39.23 |
| Support Level | $19.60 | $5.81 |
| Resistance Level | $24.56 | $10.61 |
| Average True Range (ATR) | 1.26 | 0.45 |
| MACD | -0.12 | -0.06 |
| Stochastic Oscillator | 32.46 | 4.76 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About NG Novagold Resources Inc.
Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other precious metals.